**Pan-cancer Investigation of Proteogenomic Interaction and Druggability**

Systematically evaluation of comprehensive proteogenomic profiles of 341 tumors across 3 cancer types characterized in TCGA and CPTAC projects, including 77 breast tumors, 174 ovarian tumors, and 90 colorectal tumors